Why Moderna (MRNA) Stock Is Trading Up Today [Yahoo! Finance]
Arbutus Biopharma Corporation (ABUS)
Last arbutus biopharma corporation earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.arbutusbio.com/node/5806
Company Research
Source: Yahoo! Finance
Moderna agreed to pay Arbutus Biopharma and Genevant Sciences up to $2.25 billion to resolve the legal battle. This settlement removed a major legal and financial uncertainty that had weighed on the company's stock. The agreement also provided clarity for Moderna's entire infectious disease portfolio, confirming no future royalties would be owed. In addition to the settlement news, the company received a positive opinion from the European Medicines Agency for its combination vaccine designed to protect against both influenza and COVID-19 in individuals aged 50 and older. The shares closed the day at $57.86, up 16.1% from previous close. Is now the time to buy Moderna? Access our full analysis report here, it's free What Is The Market Telling Us Moderna's shares are extremely volatile and have had 50 moves greater than 5% over the last year. But moves this big are rare even for Moderna and indicate this news significantly impacted the market's perception of the business. The
Show less
Read more
Impact Snapshot
Event Time:
ABUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABUS alerts
High impacting Arbutus Biopharma Corporation news events
Weekly update
A roundup of the hottest topics
ABUS
News
- Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement [Yahoo! Finance]Yahoo! Finance
- Moderna gains as Arbutus/ Genevant settlement removes major financial risk [Seeking Alpha]Seeking Alpha
- Moderna shares jump as settlement removes major legal overhang [Yahoo! Finance]Yahoo! Finance
- Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With ModernaGlobeNewswire
- Arbutus Biopharma: LNP Litigation And Imdusiran Drive Near-Term Catalysts [Seeking Alpha]Seeking Alpha
ABUS
Earnings
- 8/6/25 - Beat
ABUS
Sec Filings
- 3/3/26 - Form 8-K
- 2/20/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- ABUS's page on the SEC website